California Public Employees Retirement System Lowers Stock Position in Cigna Group $CI

Posted by Defense World Staff on Mar 16th, 2026

California Public Employees Retirement System trimmed its position in Cigna Group (NYSE:CI – Free Report) by 9.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 690,200 shares of the health services provider’s stock after selling 67,990 shares during the quarter. California Public Employees Retirement System owned about 0.26% of Cigna Group worth $198,950,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Cigna Group by 11.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock valued at $13,039,000 after purchasing an additional 4,738 shares during the period. Maj Invest Holding A S boosted its holdings in Cigna Group by 2.4% in the 3rd quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock worth $121,854,000 after buying an additional 10,042 shares during the period. Providence Capital Advisors LLC boosted its holdings in Cigna Group by 1,016.8% in the 3rd quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after buying an additional 7,748 shares during the period. National Pension Service increased its stake in Cigna Group by 3.2% in the 3rd quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after buying an additional 21,203 shares in the last quarter. Finally, SCS Capital Management LLC increased its stake in Cigna Group by 39.1% in the 2nd quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock worth $10,127,000 after buying an additional 8,609 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

Positive Sentiment: Sanford C. Bernstein upgraded Cigna to “outperform” and raised its price target to $358, citing PBM reform as a clearing event and improved outlook for Evernorth — a catalyst for multiple analysts to raise estimates. Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event
Positive Sentiment: Zacks notes CI trades below the industry P/E and highlights Evernorth growth, steady earnings beats and buybacks as supports for the investment case — a valuation/earnings combo that helps explain buying interest. Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
Neutral Sentiment: A valuation review highlights recent share-price weakness versus the specialty-pharmacy growth narrative — useful context for investors weighing whether current discounts already reflect execution risks. Evaluating Cigna Group (CI) Valuation After Recent Share Price Weakness And Specialty Pharmacy Growth Narrative
Neutral Sentiment: A head-to-head comparison with CVS frames Cigna as the play for stronger earnings quality and capital discipline, while reminding long-term investors to consider income, stability and valuation differences when choosing exposure. CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?
Neutral Sentiment: Zacks’ broader industry outlook continues to single out major HMOs (including Cigna) as key players in a sector balancing tech-enabled growth and policy/operational headwinds. Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene
Negative Sentiment: Barclays and commentators warn that the timing of a CEO change could surprise investors and introduce strategic/operational uncertainty during a critical execution window. Management transition risk may weigh on sentiment until plans are clearer. The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays
Negative Sentiment: Industry pieces flag escalating medical costs, nursing shortages and margin pressure as sector-wide risks that could blunt near-term earnings leverage for HMOs, including Cigna. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

Cigna Group Trading Up 0.5%

Shares of CI stock opened at $267.15 on Monday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock’s 50-day moving average price is $279.60 and its 200-day moving average price is $282.70. The stock has a market capitalization of $70.40 billion, a price-to-earnings ratio of 12.04, a price-to-earnings-growth ratio of 0.93 and a beta of 0.27.

Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is currently 28.13%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CI shares. Truist Financial boosted their price objective on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Robert W. Baird cut their target price on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Guggenheim reissued a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Finally, Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $333.11.

View Our Latest Analysis on CI

Insiders Place Their Bets

In other news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.